Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1970 Dec;7(6):793–803.

Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZB × NZW) F1 hybrid mice

B M Greenwood, A Voller
PMCID: PMC1712870  PMID: 4924107

Abstract

Female (NZB × NZW) F1 hybrid (B/W) mice were infected with Plasmodium berghei at the age of 1 month. In contrast to the high mortality from renal disease observed in control female mice of this strain, all of the malaria-infected female mice were alive at 12 months of age and none had any clinical features of severe renal disease. This finding gives some support to the hypothesis that a background of repeated parasitic infection may modify the development of autoimmune disease in man.

Full text

PDF
793

Images in this article

799Fig. 4
on p.799

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Denman A. M., Russell A. S., Denman E. J. Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol. 1969 Dec;5(6):567–595. [PMC free article] [PubMed] [Google Scholar]
  2. Denman A. M., Russell A. S., Denman E. J. Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol. 1970 Mar;6(3):325–335. [PMC free article] [PubMed] [Google Scholar]
  3. Greenwood B. M. Autoimmune disease and parasitic infections in Nigerians. Lancet. 1968 Aug 17;2(7564):380–382. doi: 10.1016/s0140-6736(68)90595-3. [DOI] [PubMed] [Google Scholar]
  4. Horowitz R. E., Dubois E. L., Weiner J., Strain L. Cyclophosphamide treatment of mouse systemic lupus erythematosus. Lab Invest. 1969 Sep;21(3):199–206. [PubMed] [Google Scholar]
  5. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  6. Huang K. Y., Schultz W. W., Gordon F. B. Interferon induced by Plasmodium berghei. Science. 1968 Oct 4;162(3849):123–124. doi: 10.1126/science.162.3849.123. [DOI] [PubMed] [Google Scholar]
  7. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Landau I., Killick-Kendrick R. Rodent plasmodia of the République Centrafricaine: the sporogony and tissue stages of Plasmodium chabaudi and P. berghei yoelii. Trans R Soc Trop Med Hyg. 1966;60(5):633–649. doi: 10.1016/0035-9203(66)90010-1. [DOI] [PubMed] [Google Scholar]
  9. MARDINEY M. R., Jr, MUELLER-EBERHARD H. J. MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol. 1965 Jun;94:877–882. [PubMed] [Google Scholar]
  10. McGiven A. R., Ironside P. N. Elution of antinuclear factor from renal lesions of NZB-NZW mice. Clin Exp Immunol. 1968 Sep;3(7):665–669. [PMC free article] [PubMed] [Google Scholar]
  11. Mellors R. C., Aoki T., Huebner R. J. Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med. 1969 May 1;129(5):1045–1062. doi: 10.1084/jem.129.5.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mellors R. C., Huang C. Y. Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med. 1967 Jul 1;126(1):53–62. doi: 10.1084/jem.126.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Prosser P. R. Particles resembling murine leukaemia virus in New Zealand black mice. Clin Exp Immunol. 1968 Mar;3(3):213–226. [PMC free article] [PubMed] [Google Scholar]
  14. Remington J. S., Merigan T. C. Resistance to virus challenge in mice infected with protozoa or bacteria. Proc Soc Exp Biol Med. 1969 Sep;131(4):1184–1188. doi: 10.3181/00379727-131-34066. [DOI] [PubMed] [Google Scholar]
  15. Russell A. S. Statolon in murine autoimmune disease. Lancet. 1968 Aug 17;2(7564):407–407. doi: 10.1016/s0140-6736(68)90627-2. [DOI] [PubMed] [Google Scholar]
  16. Russell P. J., Hicks J. D. Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet. 1968 Mar 2;1(7540):440–441. doi: 10.1016/s0140-6736(68)92778-5. [DOI] [PubMed] [Google Scholar]
  17. SIEGEL M., LEE S. L., WIDELOCK D., REILLYEB, WISE G. J., ZINGALE S. B., FUERST H. T. The epidemiology of systemic lupus erythematosus: preliminary results in New York City. J Chronic Dis. 1962 Feb;15:131–140. doi: 10.1016/0021-9681(62)90063-2. [DOI] [PubMed] [Google Scholar]
  18. Salaman M. H., Wedderburn N., Bruce-Chwatt L. J. The immunodepressive effect of a murine plasmodium and its interaction with murine oncogenic viruses. J Gen Microbiol. 1969 Dec;59(3):383–391. doi: 10.1099/00221287-59-3-383. [DOI] [PubMed] [Google Scholar]
  19. Staples P. J., Talal N. Rapid loss of tolerance induced in weanling NZB and B-W F1 mice. Science. 1969 Mar 14;163(3872):1215–1216. doi: 10.1126/science.163.3872.1215. [DOI] [PubMed] [Google Scholar]
  20. Steinberg A. D., Baron S., Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1102–1107. doi: 10.1073/pnas.63.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Turner M. W., McGregor I. A. Studies on the immunology of human malaria. I. Preliminary characterization of antigens in Plasmodium falciparum infections. Clin Exp Immunol. 1969 Jul;5(1):1–16. [PMC free article] [PubMed] [Google Scholar]
  22. VOLLER A. FLUORESCENT ANTIBODY METHODS AND THEIR USE IN MALARIA RESEARCH. Bull World Health Organ. 1964;30:343–354. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES